BIO · Bio-Rad Laboratories, Inc. · Insider Trading

$366.36 -4.12 (-1.11%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 400 member Russell 1000 member Rebalance outlook locked

Market Cap

$9.85B

26.89M

Volume · Nov 13 256.26K Avg daily vol (3M) 255.23K

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

-3

Net shares bought

-0.01%

Net buy value

-$1,247,039

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2026-11-10	ENLOE COURTNEY C	EVP, General Counsel & Sec	Sell↓	Bio-Rad A Common Stock	902	$386.17	$348,321	749
2026-11-09	BARRY JAMES	EVP, President, LSG	Sell↓ Filing footnotes — Bio-Rad A Common Stock (Direct) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $385.588 to $385.645, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.	Bio-Rad A Common Stock	1,400	$385.63	$539,876	624
2026-11-09	DiVincenzo Jonathan P.	EVP, Pres, Central Labs & Intl	Sell↓	Bio-Rad A Common Stock	919	$390.47	$358,842	1,962
2026-10-24	DiVincenzo Jonathan P.	EVP, Pres, Central Labs & Intl	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	1,869	—	—	3,740
2026-10-24	DiVincenzo Jonathan P.	EVP, Pres, Central Labs & Intl	Tax↓	Bio-Rad A Common Stock	951	$369.95	$351,822	2,881
2026-10-24	DiVincenzo Jonathan P.	EVP, Pres, Central Labs & Intl	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	1,869	—	—	3,832
2026-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Tax↓	Bio-Rad A Common Stock	487	$354.50	$172,642	4,160
2026-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	1,044	—	—	4,647
2026-10-20	EVRAN SEDAT	EVP, Global Supply Chain	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.	Restricted Stock Units	1,044	—	—	1,044
2026-09-06	BARRY JAMES	EVP, President, LSG	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	1,056	—	—	2,112
2026-09-06	ENGELHARDT EVA ANETTE	EVP, President, CDG	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	1,152	—	—	2,313
2026-09-06	EVRAN SEDAT	EVP, Global Supply Chain	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	864	—	—	1,728
2026-09-06	BARRY JAMES	EVP, President, LSG	Tax↓	Bio-Rad A Common Stock	470	$386.11	$181,472	2,024
2026-09-06	ENGELHARDT EVA ANETTE	EVP, President, CDG	Tax↓	Bio-Rad A Common Stock	485	$386.11	$187,263	1,828
2026-09-06	Allison Schwartz	Director	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	92	—	—	1,768
2026-09-06	SCHWARTZ NORMAN D	Director, Chairman & CEO, 10% Owner	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	3,455	—	—	450,873
2026-09-06	Allison Schwartz	Director	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	92	—	—	185
2026-09-06	ENGELHARDT EVA ANETTE	EVP, President, CDG	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	1,152	—	—	2,304
2026-09-06	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	1,536	—	—	4,932
2026-09-06	EVRAN SEDAT	EVP, Global Supply Chain	Tax↓	Bio-Rad A Common Stock	277	$386.11	$106,952	3,603
2026-09-06	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Tax↓	Bio-Rad A Common Stock	782	$386.11	$301,938	4,150
2026-09-06	ENLOE COURTNEY C	EVP, General Counsel & Sec	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	768	—	—	1,536
2026-09-06	SCHWARTZ NORMAN D	Director, Chairman & CEO, 10% Owner	Tax↓	Bio-Rad A Common Stock	1,854	$386.11	$715,848	449,019
2026-09-06	Allison Schwartz	Director	Tax↓	Bio-Rad A Common Stock	34	$386.11	$13,128	1,734
2026-09-06	ENLOE COURTNEY C	EVP, General Counsel & Sec	Tax↓	Bio-Rad A Common Stock	305	$386.11	$117,764	1,651
2026-09-06	SCHWARTZ NORMAN D	Director, Chairman & CEO, 10% Owner	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	3,455	—	—	6,912
2026-09-06	EVRAN SEDAT	EVP, Global Supply Chain	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	864	—	—	3,880
2026-09-06	ENLOE COURTNEY C	EVP, General Counsel & Sec	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	768	—	—	1,956
2026-09-06	BARRY JAMES	EVP, President, LSG	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	1,056	—	—	2,494
2026-09-06	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	1,536	—	—	3,072
2026-09-05	Mehta Rajat	EVP, GBL Commercial Operations	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	1,370	—	—	1,736
2026-09-05	BARRY JAMES	EVP, President, LSG	Tax↓	Bio-Rad A Common Stock	369	$386.11	$142,475	1,438
2026-09-05	Allison Schwartz	Director	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	228	—	—	1,758
2026-09-05	ENGELHARDT EVA ANETTE	EVP, President, CDG	Tax↓	Bio-Rad A Common Stock	369	$386.11	$142,475	1,161
2026-09-05	SCHWARTZ NORMAN D	Director, Chairman & CEO, 10% Owner	Tax↓	Bio-Rad A Common Stock	2,876	$386.11	$1,110,452	447,418
2026-09-05	ENLOE COURTNEY C	EVP, General Counsel & Sec	Tax↓	Bio-Rad A Common Stock	246	$386.11	$94,983	1,188
2026-09-05	ENGELHARDT EVA ANETTE	EVP, President, CDG	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	1,027	—	—	3,083
2026-09-05	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Tax↓	Bio-Rad A Common Stock	559	$386.11	$215,835	3,396
2026-09-05	Mehta Rajat	EVP, GBL Commercial Operations	Tax↓	Bio-Rad A Common Stock	233	$386.11	$89,964	366
2026-09-05	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units. Includes 22.0680 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2026.	Bio-Rad A Common Stock	1,370	—	—	3,955
2026-09-05	Allison Schwartz	Director	Tax↓	Bio-Rad A Common Stock	82	$386.11	$31,661	1,676
2026-09-05	Mehta Rajat	EVP, GBL Commercial Operations	Tax↓	Bio-Rad A Common Stock	504	$386.11	$194,599	1,232
2026-09-05	BARRY JAMES	EVP, President, LSG	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	1,027	—	—	3,083
2026-09-05	EVRAN SEDAT	EVP, Global Supply Chain	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	1,027	—	—	3,083
2026-09-05	DiVincenzo Jonathan P.	EVP, Pres, Central Labs & Intl	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	1,712	—	—	2,631
2026-09-05	BARRY JAMES	EVP, President, LSG	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units.	Bio-Rad A Common Stock	1,027	—	—	1,807
2026-09-05	Lakkaraju Roop Kalyan	EVP, Chief Financial Officer	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	1,370	—	—	4,110
2026-09-05	Mehta Rajat	EVP, GBL Commercial Operations	Convert↑ Filing footnotes — Bio-Rad A Common Stock (Direct) Shares of Class A common stock acquired on the vesting of restricted stock units. Includes 57.9370, 53.0810 and 32.0340 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2025, 03/31/2026 and 06/30/2026, respectively.	Bio-Rad A Common Stock	456	—	—	599
2026-09-05	Allison Schwartz	Director	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	228	—	—	686
2026-09-05	SCHWARTZ NORMAN D	Director, Chairman & CEO, 10% Owner	Convert↓ Filing footnotes — Restricted Stock Units (Direct) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.	Restricted Stock Units	4,109	—	—	12,330

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–50 of 1,000 transactions

Key facts CIK 12208 CUSIP 090572207 13F (30d) 356 filings 307 filers Visit website Investor relations